SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans

AIDS

Volumn 16, Issue 11, 2002, Pages 1489-1496

  Ling, Binhua ^a,b   Veazey, Ronald S ^a   Luckay, Amara ^b   Penedo, Cecilia ^c   Xu, Keyu ^a   Lifson, Jeffrey D ^d   Marx, Preston A ^a,b  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HIV; Intestinal effector cells; Macaque; Rhesus; SIV; Subspecies; Viral load

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CHINESE; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; EFFECTOR CELL; EXPERIMENTAL INFECTION; GENETIC ANALYSIS; GEOGRAPHIC ORIGIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIAN; INTERMETHOD COMPARISON; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE; MACACA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; VIRUS LOAD; VIRUS PATHOGENESIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; BLOOD; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHINA; CLASSIFICATION; GENETICS; IMMUNOLOGY; INDIA; MONKEY DISEASE; PATHOGENICITY; PATHOPHYSIOLOGY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMAL; ANTIBODIES, VIRAL; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHINA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INDIA; MACACA MULATTA; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIV; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL LOAD; ANIMALS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0037178321     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207260-00005     Document Type: Article

References (26)

1. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: Predictive value for disease progression
2. Role of CD8+ lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
3. Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: Relation to CD4 cell count and clinical course of primary infection
4. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
5. Viral dynamics in primary HIV-1 infection
6. Vaccine studies stymied by shortage of animals
7. Genetic heterogeneity in five captive specific pathogen-free groups of rhesus macaques
8. mac Gag peptide-specific cytotoxic T-lymphocyte assay
9. Additionally highly polymorphic microsatellite (STR) loci for estimating kinship in rhesus macaques (Macaca mulatta)
10. A parentage test for rhesus macaques using human primers for microsatellite markers
11. Characterization of rhesus macaque B-lymphoblastoid cell lines infected with simian type D retrovirus
12. Temporal analysis of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine
13. Dynamics of CCR5 expression by CD4+ T cells in lymphoid tissues during simian immunodeficiency virus infection
14. The molecular basis and evolutionary history of a microsatellite null allele in bears
15. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection - Evidence for highly susceptible human hosts
16. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
17. Rapid mucosal CD4+ T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques
18. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: Highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo
19. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
20. The mucosal immune system: Primary target for HIV infection and AIDS
21. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission
22. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques
23. Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center
24. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
25. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine